Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Belg ; 47(1-4): 8-10, 1989.
Article in French | MEDLINE | ID: mdl-2610579

ABSTRACT

The combined vaccine against measles, mumps and rubella provides an efficient tool for the elimination of these three diseases in a community. In the French Community of Belgium the MMR vaccine is commercially available since 1984 and was officially included in the immunization schedule in 1985. The present coverage rate is estimated at 60% of the children under 24 month. To improve the situation, the "Conseil Consultatif Communautaire de Prévention pour la Santé" of the French Community of Belgium has proposed a programme of MMR immunization promotion based on a coordinated mobilization of the various structures involved i.e. MCH organization, school medicine, general practitioners, pediatricians, Faculties of medicine and Health Administration. The programme has been adopted by the political authority and has started on February 1st 1989.


Subject(s)
Measles Vaccine/therapeutic use , Mumps Vaccine/therapeutic use , Rubella Vaccine/therapeutic use , Belgium , Child , Child, Preschool , Drug Combinations/therapeutic use , Humans , Immunization/statistics & numerical data , Infant , Measles-Mumps-Rubella Vaccine
SELECTION OF CITATIONS
SEARCH DETAIL
...